Yes, you can get a false herpes test result, but the risk depends on the test, the timing, and the person's prior probability of infection. Swab PCR tests rarely produce false positives; their main weakness is false negatives when a lesion is healing or the sample misses virus. Type-specific IgG blood tests can be falsely positive, especially when the positive index is low or HSV-2 prevalence is low. IgG tests can also be falsely negative in the first 12 to 16 weeks after exposure. IgM tests are especially unreliable.
How False Herpes Test Results Happen
A herpes test is not one thing. PCR detects viral DNA, culture grows live virus, and IgG measures antibodies. False results arise when the test signal and the true infection state disagree. Four mechanisms dominate: timing, cross-reactivity, specimen quality, and low prior probability.
Sensitivity is the share of infected people who test positive. Specificity is the share of uninfected people who test negative. For a type-specific IgG assay with 95% sensitivity and 98% specificity, positive predictive value changes sharply with prevalence. At 2% prevalence, about 49% of positive results would be true positives. At 12% prevalence, about 87% would be true positives.
In a 10,000-person model, the same assay creates 190 true positives and 196 false positives at 2% prevalence. At 12% prevalence, it creates 1,140 true positives and 176 false positives. Those numbers are illustrative, not a promise about any single commercial kit. They show why a positive result is a probability, not a verdict.
The mechanism is Bayesian, not mysterious. A test moves your estimated probability up or down from where it started. If the starting probability is very low, even a good test can produce more false positives than true positives. If the starting probability is higher, the same positive result is more likely to be real.
In plain terms: a positive result is a probability, not a verdict.
Can You Get a False Herpes Test Result? The Causes
Can you get a false herpes test result from a blood test? Yes, and the cause usually falls into one of two buckets: a false positive or a false negative. False positives are most common with antibody tests, especially IgM and low-positive IgG. False negatives are most common with early IgG testing or poorly collected swab samples.
Type-specific IgG tests target HSV-1 or HSV-2 glycoprotein G. Cross-reactivity with other herpesviruses can occur, though modern assays reduce it. Low-positive index values are a known gray zone. Many labs report an index of 1.1 to 3.5 as low positive. Per CDC's 2021 STI treatment guidelines, low-positive type-specific IgG results need confirmation. That confirmation can use an inhibition assay or Western blot.
IgM is not recommended for diagnosing genital herpes. It can be positive during reactivation, not just new infection. It can also cross-react with Epstein-Barr virus, cytomegalovirus, and rheumatoid factor. Per CDC's 2021 STI treatment guidelines, IgM testing should not be used to diagnose genital herpes because it is not type-specific and cannot separate new infection from old infection.
Early IgG testing is a major source of false negatives. Most people seroconvert by 12 weeks, but some take up to 16 weeks. A negative IgG at 2 weeks cannot rule out infection. PCR on a fresh lesion is more useful during that window.
PCR sensitivity is commonly around 90% to 95% with a good specimen. It falls when the lesion is crusted, healing, or swabbed without viral material. Viral culture is less sensitive than PCR and falls faster as lesions heal. A negative culture from a late lesion is weak evidence against herpes.
Specimen quality matters more than many people expect. A swab must touch the base of a fresh vesicle or ulcer. A dry swab, a crusted lesion, or a sample taken after antiviral treatment can lower detection. Lab contamination can cause a PCR false positive, but that is uncommon with good technique.
Timing: When Herpes Tests Turn Positive
Timing explains many false results. The right test at the wrong time can be misleading. The table below separates the early lesion window from the antibody window.
| Time after exposure | What the test can show | Main false-result risk |
|---|---|---|
| Day 0 to 3 | PCR or culture may detect virus if a fresh lesion is present | False negative if no lesion is present or the swab misses virus |
| Days 2 to 7 | PCR is most sensitive in a vesicle or early ulcer | False negative if the lesion is crusted or healing |
| Weeks 1 to 3 | IgM may appear, but it is not type-specific | False positive and false negative are both common; IgM is not diagnostic |
| Weeks 2 to 6 | IgG may turn positive in some people | False negative if the immune response is still early |
| Weeks 6 to 12 | Most people have detectable IgG | False negative becomes less likely but still possible |
| Weeks 12 to 16 | Nearly all people have detectable IgG | A negative result is more reliable but still assay-dependent |
| After 16 weeks | IgG is usually stable | False positive risk depends on specificity and prior probability |
The 12-to-16-week window is not a guarantee. A negative IgG after 16 weeks is more reliable, but it still depends on assay specificity. If a person has no lesions, PCR cannot be used, so serology is the only option. That is why prior probability matters so much.
A positive PCR from a fresh lesion is strong evidence. A negative PCR from a healing lesion is weaker. A positive IgG without symptoms needs context. A negative IgG too early needs repetition.
Accuracy Limits: Sensitivity, Specificity, and Positive Predictive Value
No HSV test has perfect accuracy. Reported sensitivity and specificity vary by assay, specimen, and population. The comparison below focuses on the main false-result pattern for each test type.
| Test | What it detects | Best use | Main false-result pattern |
|---|---|---|---|
| PCR swab | Viral DNA | Active genital or oral lesions | False positives are uncommon; false negatives occur with poor specimens or healing lesions |
| Viral culture | Live virus | Fresh vesicles, when PCR is unavailable | Lower sensitivity than PCR; false negatives rise as lesions crust |
| Type-specific IgG | Antibodies to HSV-1 or HSV-2 | Testing 12 to 16 weeks after exposure | False positives with low index or cross-reactivity; false negatives early |
| IgM | Early antibodies, not type-specific | Not recommended for genital herpes diagnosis | False positives and false negatives are common; cannot separate new from old infection |
| Western blot or inhibition assay | Confirmatory antibody pattern | Confirming a low-positive or discordant IgG | High specificity but not first-line; false results are less likely but not impossible |
The most important limit is not the kit's label; it is the person's starting probability. A 99% specific test still produces many false positives when prevalence is 1%. At 1% prevalence, a 10,000-person model with 95% sensitivity and 99% specificity yields about 95 true positives and 99 false positives. That is why screening low-risk people without symptoms can do more harm than good. Per CDC's 2021 STI treatment guidelines, routine HSV-2 serologic screening is not recommended for asymptomatic people.
The 12-to-16-week window describes when antibodies usually appear. The 1.1-to-3.5 index describes a low-positive antibody signal after it appears. Those are separate thresholds: one is about timing, the other about signal strength.
In plain terms: a highly specific test can still be wrong often when the disease is rare.
Variations: HSV-1, HSV-2, Pregnancy, and Immunity
Variations in prevalence and immune status change the false-result math. HSV-2 prevalence in U.S. adults aged 14 to 49 is about 12%, per CDC's 2015-2016 NHANES analysis. HSV-1 prevalence is much higher, roughly half of adults in many U.S. surveys. Because HSV-2 is less common, a positive HSV-2 IgG has a lower positive predictive value than a positive HSV-1 IgG.
HSV-1 can cause genital herpes, and HSV-2 can cause oral herpes. Antibody type does not tell you where the infection lives. That is a common source of confusion after a positive blood test. A positive HSV-1 IgG may reflect oral cold sores, genital infection, or both.
Pregnancy raises the stakes without changing the test's limits. Per CDC's 2021 STI treatment guidelines, routine HSV-2 serologic screening is not recommended for asymptomatic pregnant women. False positives in pregnancy can trigger unnecessary anxiety, extra visits, and sometimes unnecessary antiviral use. The real safety priority is preventing neonatal herpes through lesion assessment at delivery.
Immunocompromised people can have higher prevalence and atypical lesions. PCR is preferred for active lesions because serology may be blunted or delayed. People with HIV may seroconvert normally, but severe disease can alter presentation. Neonates and people with eye symptoms are edge cases where false reassurance is dangerous.
Misconceptions About False Herpes Test Results
One common misconception is that IgM is the best test for a new infection. In reality, IgM is not type-specific and can stay positive for months or appear during reactivation. It can also cross-react with other herpesviruses and rheumatoid factor. That is why CDC does not recommend IgM for genital herpes diagnosis.
Another misconception is that a negative IgG at two weeks rules out herpes. The antibody window can extend to 12 or 16 weeks. A negative early result is a snapshot, not a clearance certificate.
Some people think a positive IgG identifies the infection site. It does not. HSV-1 and HSV-2 antibodies show type exposure, not whether the virus is oral, genital, or both.
PCR false positives are often feared, but they are uncommon with good lab technique. False negatives from a missed lesion or poor swab are more common. A negative swab does not erase a strong clinical picture.
A low-positive IgG is not proof of infection. Many labs use an index of 1.1 to 3.5 as a gray zone. Confirmatory testing is the next step, not immediate certainty. If you are asking can you get a false herpes test result, a low-positive IgG is one of the clearest examples.
What to Actually Do After an Unexpected Herpes Result
Start by asking which test was run and what the result value was. A positive IgG result should include the type and the index value. If the index is low positive, ask for confirmatory testing by inhibition assay or Western blot. Do not order an IgM test to clarify the result.
If you have active lesions, get a PCR swab within 24 to 48 hours of a new lesion. A fresh vesicle is the best specimen. A crusted or healing lesion is more likely to produce a false negative.
If you are pregnant, tell your clinician about any new genital lesion. Pregnancy changes the urgency, especially near delivery. If confirmation is unavailable, repeat type-specific IgG at 12 to 16 weeks after the suspected exposure.
Partner testing can help interpret a borderline result. If a partner has confirmed HSV-2, the prior probability is higher. That raises the positive predictive value of your test.
Antiviral treatment should be guided by symptoms, lesions, and confirmed testing. Do not start or stop medication based on one borderline blood test. Seek urgent care for red-flag features.
- Severe headache, confusion, fever, or neck stiffness with genital ulcers.
- Eye pain, redness, blurred vision, or sensitivity to light.
- New genital lesions in late pregnancy or exposure of a newborn to a herpes lesion.
- Widespread or unusually severe lesions in an immunocompromised person.
- Inability to urinate or severe pelvic pain with genital ulcers.
- A positive result being used to make a permanent decision without confirmatory testing.
The next step is confirmation, not assumption.